Commentary: Despite reports of catastrophic complications, why recombinant human bone morphogenetic protein-2 should be available for use in anterior cervical spine surgery. uri icon

Overview

publication date

  • October 1, 2012

Research

keywords

  • Adverse Drug Reaction Reporting Systems
  • Bone Morphogenetic Protein 2
  • Databases, Factual
  • Transforming Growth Factor beta

Identity

Scopus Document Identifier

  • 84870260044

Digital Object Identifier (DOI)

  • 10.1016/j.spinee.2012.10.010

PubMed ID

  • 23199821

Additional Document Info

volume

  • 12

issue

  • 10